Larimar Therapeutics stock dips after pricing $100M share offering
Source: SeekingAlpha
2026-02-26 04:08:53 ET
More on Larimar Therapeutics
- Larimar Therapeutics: The Market Is Mispricing A Potential Standard Of Care
- Larimar Therapeutics, Inc. (LRMR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Larimar Therapeutics, Inc. (LRMR) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- Larimar Therapeutics launches proposed $75 million public offering
- Larimar surges on FDA breakthrough status for lead asset
Read the full article on Seeking Alpha
For further details see:
Larimar Therapeutics stock dips after pricing $100M share offering
Larimar Therapeutics Inc.
NASDAQ: LRMR
LRMR Trading
-4.2% G/L:
$5.245 Last:
892,222 Volume:
$5.36 Open:
LRMR Latest News
March 04, 2026 04:05:00 pm
Larimar Therapeutics to Participate in Upcoming Investor Conferences in March
February 25, 2026 08:59:46 pm
Larimar Therapeutics Announces Pricing of Upsized $100 Million Underwritten Public Offering
February 25, 2026 04:01:00 pm
Larimar Therapeutics Announces Proposed $75 Million Underwritten Public Offering
February 24, 2026 07:56:05 pm
$38M Defense Backlog vs. $6M Market Cap, Breakthrough Biotech Data, and the Quantum Security Land Grab
LRMR Stock Data
$285,016,005
38,430,086
1.32%
48
N/A
Biotechnology & Life Sciences
Healthcare
US
Bala Cynwyd
